Msn Life Sciences Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DESVENLAFAXINE SUCCINATE MONOHYDRATE USP (FORM-II) [ROUTE CODE "SL"], with a corresponding US DMF Number 31157.
Remarkably, this DMF maintains an Active status since its submission on November 29, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 20, 2017, and payment made on August 28, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II